BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1675637)

  • 1. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
    Selmi S; Samuels HH
    J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.
    Forman BM; Yang CR; Au M; Casanova J; Ghysdael J; Samuels HH
    Mol Endocrinol; 1989 Oct; 3(10):1610-26. PubMed ID: 2558297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
    Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
    Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
    Rascle A; Ferrand N; Gandrillon O; Samarut J
    Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein.
    Goldberg Y; Glineur C; Gesquière JC; Ricouart A; Sap J; Vennström B; Ghysdael J
    EMBO J; 1988 Aug; 7(8):2425-33. PubMed ID: 2903825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.
    Bigler J; Hokanson W; Eisenman RN
    Mol Cell Biol; 1992 May; 12(5):2406-17. PubMed ID: 1314955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.
    Bonde BG; Sharif M; Privalsky ML
    J Virol; 1991 Apr; 65(4):2037-46. PubMed ID: 1672166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the v-erbA protein is required for its function as an oncogene.
    Glineur C; Zenke M; Beug H; Ghysdael J
    Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
    Zenke M; Muñoz A; Sap J; Vennström B; Beug H
    Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. v-erbA acts on retinoic acid receptors in immature avian erythroid cells.
    Sande S; Sharif M; Chen H; Privalsky M
    J Virol; 1993 Feb; 67(2):1067-74. PubMed ID: 8093487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
    de Verneuil H; Metzger D
    Nucleic Acids Res; 1990 Aug; 18(15):4489-97. PubMed ID: 1975094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.
    Baniahmad A; Köhne AC; Renkawitz R
    EMBO J; 1992 Mar; 11(3):1015-23. PubMed ID: 1347744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated.
    Privalsky ML
    J Virol; 1990 Jan; 64(1):463-6. PubMed ID: 1967151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
    Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M
    Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
    Harbers M; Wahlström GM; Vennström B
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors.
    Desbois C; Aubert D; Legrand C; Pain B; Samarut J
    Cell; 1991 Nov; 67(4):731-40. PubMed ID: 1682056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.